QBE INSURANCE GROUP LIMITED (QBE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

QBE

QBE - QBE INSURANCE GROUP LIMITED

FNArena Sector : Insurance
Year End: December
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX20 | ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

QBE Insurance Group is an Australian insurance company operating in North America, Europe, Australia & New Zealand and the Asia Pacific region. It was listed in 1973 following the merger of three companies whose names represent the letters of the combined company.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$21.55

02 May
2025

0.100

OPEN

$21.52

0.47%

HIGH

$21.79

3,694,272

LOW

$21.38

TARGET
$23.349 8.3% upside
Franking for last dividend paid out: 20%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . MPL . NHF . NOL . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
QBE: 1
Title FY25
Forecast		 FY26
Forecast
EPS (cps) 179.3 xxx
DPS (cps) 89.2 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 11.9 xxx
Dividend Yield 4.2% xxx
Div Pay Ratio(%) 49.7% xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 6.86%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 4.08

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 16/08 - ex-div 24c (franking 20%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx174.6
DPS All xxxxxxxxxxxxxxx87.0
Sales/Revenue xxxxxxxxxxxxxxx34,596.8 M
Book Value Per Share xxxxxxxxxxxxxxx1,151.3
Net Operating Cash Flow xxxxxxxxxxxxxxx3,903.9 M
Net Profit Margin xxxxxxxxxxxxxxx7.80 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx16.43 %
Return on Invested Capital xxxxxxxxxxxxxxx13.68 %
Return on Assets xxxxxxxxxxxxxxx3.99 %
Return on Equity xxxxxxxxxxxxxxx16.90 %
Return on Total Capital xxxxxxxxxxxxxxx19.50 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx2,841.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx570 M
Long Term Debt xxxxxxxxxxxxxxx4,106 M
Total Debt xxxxxxxxxxxxxxx4,676 M
Goodwill - Gross xxxxxxxxxxxxxxx2,374 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx2,646 M
Price To Book Value xxxxxxxxxxxxxxx1.67

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx230.4 M
Capex % of Sales xxxxxxxxxxxxxxx0.67 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx2,213 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx47,252 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.7

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

03/04/2025

1

Buy

$24.60

14.15%

UBS notes the mark-to-market earnings changes for general insurers and private health insurers were relatively modest. The impacts for general insurers have been offset by an improved 2H25 for CAT costs relative to above-budget consensus estimates, the broker explains.

Across the sector, UBS prefers QBE Insurance due to valuation, and Medibank Private ((MPL)) among private health insurers, with Steadfast Group ((SDF)) preferred among insurance brokers.

QBE target price is raised to $24.60 from $24.40 with a Buy rating unchanged.

FORECAST
UBS forecasts a full year FY25 dividend of 97.00 cents and EPS of 178.32 cents.
UBS forecasts a full year FY26 dividend of 103.00 cents and EPS of 190.62 cents.

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Goldman Sachs

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

20/04/2025

1

Buy

$24.10

11.83%

Given volatility in financial markets, Jarden extended its March quarter mark-to-market for insurers and brokers to April 11.

During this period, US and Australian risk-free rates fell, equity markets declined, USD depreciated, US credit spreads widened, though Australia was more muted, and 10-year inflation breakeven fell in the US and Australia.

QBE Insurance was an exception, seeing a lift in target price due to forex benefit from USD depreciation relative to GBP/EUR. The broker cut FY25 forecast EPS by -5.7% but raised FY26 by 3.2%.

Buy. Target rises to $24.10 from $23.65.

FORECAST
Jarden forecasts a full year FY25 dividend of 91.00 cents and EPS of 166.79 cents.
Jarden forecasts a full year FY26 dividend of 104.00 cents and EPS of 193.70 cents.
Access Extra Coverage Research History >

QBE STOCK CHART

FNArena News on QBE

1
Australian Broker Call *Extra* Edition – May 05, 2025

10:35 AM - Daily Market Reports
2
Next Week At A Glance – 5-9 May 2025

May 02 2025 - Weekly Reports
3
Rudi’s View: Mag7 Dominance & Profit Warnings

May 01 2025 - Rudi's View
4
Australian Broker Call *Extra* Edition – Apr 30, 2025

Apr 30 2025 - Daily Market Reports
5
Australian Broker Call *Extra* Edition – Apr 27, 2025

Apr 28 2025 - Daily Market Reports

Latest Insurance News

1
Insurers To Pamper Shareholders With Buybacks

Jan 24 2025 - Australia
2
IAG Shares Breaking Out

Jan 21 2025 - Technicals
3
ESG Focus: The Little Big Things – 21-11-2024

Nov 21 2024 - ESG Focus
4
New-Look Suncorp Ready To Rumble

Nov 14 2024 - Australia
5
Steadfast’s Long March

Jul 02 2024 - Australia
6
AUB Group Shares Poised For Break-Out

Jun 13 2024 - Technicals
7
SMSFundamentals: Older People Are Life Insurers’ Future Challenge

Oct 26 2023 - SMSFundamentals
8
Australian Insurers And The Weather

Oct 19 2023 - Feature Stories
9
Steadfast Group’s US Entry Full Of Promise

Oct 11 2023 - Australia
10
Pros And Cons Of Insurance Companies

Aug 02 2023 - Australia